These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

580 related items for PubMed ID: 12114528

  • 21. Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region.
    Burns CC, Shaw J, Campagnoli R, Jorba J, Vincent A, Quay J, Kew O.
    J Virol; 2006 Apr; 80(7):3259-72. PubMed ID: 16537593
    [Abstract] [Full Text] [Related]

  • 22. The pathogenesis of poliomyelitis: what we don't know.
    Nathanson N.
    Adv Virus Res; 2008 Apr; 71():1-50. PubMed ID: 18585526
    [Abstract] [Full Text] [Related]

  • 23. The molecular basis of poliovirus neurovirulence.
    Ohka S, Nomoto A.
    Dev Biol (Basel); 2001 Apr; 105():51-8. PubMed ID: 11763337
    [Abstract] [Full Text] [Related]

  • 24. Construction of infectious clones for RNA viruses: TMV.
    Chapman SN.
    Methods Mol Biol; 2008 Apr; 451():477-90. PubMed ID: 18370275
    [Abstract] [Full Text] [Related]

  • 25. Blockade of the poliovirus-induced cytopathic effect in neural cells by monoclonal antibody against poliovirus or the human poliovirus receptor.
    Yanagiya A, Jia Q, Ohka S, Horie H, Nomoto A.
    J Virol; 2005 Feb; 79(3):1523-32. PubMed ID: 15650178
    [Abstract] [Full Text] [Related]

  • 26. Differences in the UV-crosslinking patterns of the poliovirus 5'-untranslated region with cell proteins from poliovirus-susceptible and -resistant tissues.
    Gutiérrez-Escolano AL, Medina F, Racaniello VR, Del Angel RM.
    Virology; 1997 Jan 20; 227(2):505-8. PubMed ID: 9018151
    [Abstract] [Full Text] [Related]

  • 27. Hematopoietic cells from CD155-transgenic mice express CD155 and support poliovirus replication ex vivo.
    Freistadt MS, Eberle KE.
    Microb Pathog; 2000 Oct 20; 29(4):203-12. PubMed ID: 10993739
    [Abstract] [Full Text] [Related]

  • 28. Poliovirus-sensitive transgenic mice as a new animal model.
    Koike S, Horie H, Sato Y, Ise I, Taya C, Nomura T, Yoshioka I, Yonekawa H, Nomoto A.
    Dev Biol Stand; 1993 Oct 20; 78():101-7. PubMed ID: 8388819
    [Abstract] [Full Text] [Related]

  • 29. In vitro synthesis of infectious poliovirus RNA.
    Kaplan G, Lubinski J, Dasgupta A, Racaniello VR.
    Proc Natl Acad Sci U S A; 1985 Dec 20; 82(24):8424-8. PubMed ID: 3001703
    [Abstract] [Full Text] [Related]

  • 30. Expression of mutated poliovirus receptors in human neuroblastoma cells persistently infected with poliovirus.
    Pavio N, Couderc T, Girard S, Sgro JY, Blondel B, Colbère-Garapin F.
    Virology; 2000 Sep 01; 274(2):331-42. PubMed ID: 10964776
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Genetic basis of attenuation of the Sabin oral poliovirus vaccines.
    Minor PD, Macadam AJ, Stone DM, Almond JW.
    Biologicals; 1993 Dec 01; 21(4):357-63. PubMed ID: 8024751
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Poliovirus neurovirulence and attenuation, a conceptual framework.
    John TJ.
    Dev Biol Stand; 1993 Dec 01; 78():117-9. PubMed ID: 8388822
    [No Abstract] [Full Text] [Related]

  • 36. Retrograde transport of intact poliovirus through the axon via the fast transport system.
    Ohka S, Yang WX, Terada E, Iwasaki K, Nomoto A.
    Virology; 1998 Oct 10; 250(1):67-75. PubMed ID: 9770421
    [Abstract] [Full Text] [Related]

  • 37. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor.
    Yang WX, Terasaki T, Shiroki K, Ohka S, Aoki J, Tanabe S, Nomura T, Terada E, Sugiyama Y, Nomoto A.
    Virology; 1997 Mar 17; 229(2):421-8. PubMed ID: 9126254
    [Abstract] [Full Text] [Related]

  • 38. Characterization of mouse lines transgenic with the human poliovirus receptor gene.
    Deatly AM, Taffs RE, McAuliffe JM, Nawoschik SP, Coleman JW, McMullen G, Weeks-Levy C, Johnson AJ, Racaniello VR.
    Microb Pathog; 1998 Jul 17; 25(1):43-54. PubMed ID: 9705248
    [Abstract] [Full Text] [Related]

  • 39. Growth phenotypes and biosafety profiles in poliovirus-receptor transgenic mice of recombinant oncolytic polio/human rhinoviruses.
    Cello J, Toyoda H, Dejesus N, Dobrikova EY, Gromeier M, Wimmer E.
    J Med Virol; 2008 Feb 17; 80(2):352-9. PubMed ID: 18098139
    [Abstract] [Full Text] [Related]

  • 40. Attachment of neutralizing antibodies stabilizes the capsid of poliovirus against uncoating.
    Wetz K.
    Virology; 1993 Feb 17; 192(2):465-72. PubMed ID: 8380661
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.